CLERIVY's U.S. debut includes a hydrocolloid patch and a water-soluble microdart patch featuring niacinamide, tranexamic acid and a vitamin C derivative. A separate OTC acne patch with 2% salicylic acid is scheduled for release in October 2026. SEOUL, South Korea, , Aug. 26, 2026 /PRNewswire/ -- Korean skincare...
SHENZHEN, China, Jan. 13, 2025 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG), an integrated service provider focusing on garment manufacturing,...
- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine
- Based on the Excellent Safety and Immune Response in...
STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...
SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Platform tokens have gained increased attention in this bull market, with notable examples from leading exchanges. Amid this...
SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment...
